This Hedge Fund Scored Big Off Amazon's Whole Foods Deal: Check Out Its 2 Dividend Stocks

Zinger Key Points
  • Barry Rosenstein is famously known for earning $300M over the merger of Whole Foods with Amazon.com in 2017.
  • For fiscal 2023, organic net sales growth is expected to be 4% to 5% compared to fiscal 2022 organic net sales of 3.8%.

Jana Partners, the activist hedge fund founded by Barry Rosenstein, grabbed headlines in 2017 when it earned $300 million off Amazon.com's AMZN acquisition of Whole Foods.

The fund's top position is in Treehouse Food Inc. THS. Jana holds more than 5 million shares, accounting for 19% of the portfolio.

Although Treehouse is not offering a dividend, here are two other dividend stocks Rosenstein’s hedge fund holds.

See Also: Watch Out! This Activist Investor May Put Pressure On These 3 High-Yielding Stocks

  • Conagra Brands Inc. CAG offers a dividend yield of 3.89% or $1.32 per share annually, making quarterly payments, with a decent track record of increasing its dividends for two consecutive years. The Chicago-based packaged food company operates predominantly in the U.S. accounting for over 90% of its revenue and profits. For fiscal 2023, organic net sales growth is expected to be 4% to 5% compared to fiscal 2022 organic net sales of 3.8%, and adjusted earnings per share growth of 1% to 5% compared to fiscal 2022.
  • Laboratory Corporation of America Holdings LH offers a dividend yield of 1.33% or $2.88 per share annually, utilizing quarterly payments, with an inconsistent track record of increasing its dividends. Laboratory, based in Burlington, North Carolina, has roughly 20% of the independent lab market acquired. The firm operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from routine blood and urine screens to complex oncology and genomic testing. During the second quarter, Laboratory invested $99.8 million in acquisitions, paid out $66.7 million in dividends, and repurchased $400 million of stock representing approximately 1.7 million shares. Additionally, full-year 2022 guidance adjusted earnings per share was raised to $19.00 to $21.25.

Also Read: Domino's Pizza To $385? Plus This Analyst Cuts Price Target On Adaptimmune Therapeutics By Around 79%

Market News and Data brought to you by Benzinga APIs
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: EarningsLarge CapLong IdeasNewsGuidanceDividendsDividendsHealth CareHedge FundsBuybacksTrading IdeasGeneralDividend Stocks That Hedge Funds HoldHedge Funds With Big PositionsHigh Yielding Dividend Stocks Hedge Funds Hold
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...